Neulasta Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions:   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent B Acute Lymphoblastic Leukemia;   Recurrent T Acute Lymphoblastic Leukemia;   Refractory B Acute Lymphoblastic Leukemia;   Refractory Lymphoblastic Lymphoma;   Refractory T Acute Lymphoblastic Leukemia Interventions:   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dexamethasone;   Biological: Filgrastim-sndz;   Drug: Leucovorin;   Drug: Mercaptopurine;   Drug: Mesna;   Drug: Methotrexate;   Biological: Pegfilgrastim;   Drug: Prednisone;   Biological: Rituximab;   Biological: Tagrax ofusp-erzs;   Drug:...
Source: ClinicalTrials.gov - September 2, 2021 Category: Research Source Type: clinical trials